Kintara Therapeutics logo

Kintara Therapeutics KTRA

$ 7.54 3179.25%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Country

usaUSA

IPO year

-

Industry

-

Stock Exchange

NASDAQ CAPITAL

CEO

-

Employees in the company

-

Shares

26.4 M

Market Cap[1]

$ 199 M

EBITDA (LTM)

$ 75 K

P/E (LTM)

-0.11

P/S (LTM)

-

EPS (LTM)

-65.58

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.